COMBINATION OF METFORMIN R-(+) LIPOATE AND ANTIHYPERLIPIDEMIC AGENTS FOR THE TREATMENT OF DIABETIC HYPERGLYCEMIA AND DIABETIC COMPLICATIONS

摘要

Disclosed are pharmaceutical compositions, methods, and kits comprising metformin R-(+) lipoate and an antihyperlipidemic agent or a pharmaceutically acceptable salt, hydrate, solvate and prodrug derivative thereof for the treatment of Type 2 diabetic hyperglycemia and diabetic complications.